Research ArticleOpen AccessGoogle Scholar indexed
Toward understanding the role of p53 in cardiovascular diseases
Bioclues.org, IKP Knowledge Park, Secunderabad, India
Instituto Peruano de Energía Nuclear, Centro Nuclear RACSO, Lima, Perú
Department of Genetics, Osmania University, Hyderabad, India
Bioclues.org, IKP Knowledge Park, Secunderabad, India
- 1 Bioclues.org, IKP Knowledge Park, Secunderabad, India
- 2 Instituto Peruano de Energía Nuclear, Centro Nuclear RACSO, Lima, Perú
- 3 Department of Genetics, Osmania University, Hyderabad, India
- 4 Bioclues.org, IKP Knowledge Park, Secunderabad, India
Journal of Biomedical Science and Engineering·Volume 06 (2013)·Pages 209–212·Published 27 February 2013·DOI10.4236/jbise.2013.62A025
Copy link · social · email
Abstract
Tumour suppressor protein 53 (TP53 or simply p53) is a well known protein linked to apoptosis, cell signalling, cascading and several myriad functions in cells. Many diseases are linked to p53 though analysis show only 216 interaction partners. Whether p53 plays an important role in cardiovascular diseases (CVD) remains uncertain. Through this bioinformatical analysis, we propose that p53 might play a major role in CVD whilst being linked to Hypoxia and Lupus. There could be evidence by pull down assay studies. Whether its interactants play a role in CVD remains to be studied using experiments, though the interaction maps show possible affect on other diseases.
KeywordsTP53Cardiovascular DiseaseProtein-Protein Interactions
- Bai, L. and Zhu, W.-G. (2006) p53: Structure, function and therapeutic applications. Journal of Cancer Molecules, 2, 141-153.
- National Center for Biotechnology Information (US) (1998) The p53 tumor suppressor protein. Genes and Disease, National Center for Biotechnology Information (US), Bethesda. http://www.ncbi.nlm.nih.gov/books/NBK22268/
- Levine, A.J. and Oren, M. (2009) The first 30 years of p53: Growing ever more complex. Nature Reviews Cancer, 9, 749-758. doi:10.1038/nrc2723
- Borradaile, N.M. and Pickering, J.G. (2009) NAD(+), sirtuins, and cardiovascular disease. Current Pharmaceutical Design, 15, 110-117. doi:10.2174/138161209787185742
- Sano, M. and Komuro, I. (2008) P53 and its role in the development of heart failure. Japanese Journal of Clinical Medicine, 66, 1013-1021.
- Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., et al. (2007) p53-induced inhibition of hif-1 causes cardiac dysfunction during pressure overload. Nature, 446, 444-448.
- Tsoporis, J.N., Mohammadzadeh, F., Parker, T.G. (2011) S100B: A multifunctional role in cardiovascular patho physiology. Amino Acids, 41, 843-847. doi:10.1007/s00726-010-0527-1
- Mercer, J., Mahmoudi, M. and Bennett, M. (2007) DNA damage, p53, apoptosis and vascular disease. Mutation Research, 621, 75-86. doi:10.1016/j.mrfmmm.2007.02.011
- Warde-Farley, D., Donaldson, S.L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., Franz, M., Grouios, C., Kazi, F., Lopes, C.T., Maitland, A., Mostafavi, S., Montojo, J., Shao, Q., Wright, G., Bader, G.D. and Morris, Q. (2010) The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Research, 38, W214-W220. doi:10.1093/nar/gkq537
- Stelzer, G., Dalah, I., Iny Stein, T., Satanower, Y., Rosen, N., Nativ, N., Oz-Levi, D., Olender, T., Belinky, F., Bahir, I., Krug, H., Perco, P., Mayer, B., Kolker, E., Safran, M. and Lancet, D. (2011) In-silico human genomics with genecards. Human Genomics, 5, 709-717. doi:10.1186/1479-7364-5-6-709
- Breitkreutz, B.J., Stark, C. and Tyers, M. (2003) Osprey: A network visualization system. Genome Biology, 4, R22. doi:10.1186/gb-2003-4-3-r22
- Nemchenko, A., Chiong, M., Turer, A., Lavandero, S. and Hill, J.A. (2011) Autophagy as a therapeutic target in cardiovascular disease. Journal of Molecular and Cellular Cardiology, 51, 584-593. doi:10.1016/j.yjmcc.2011.06.010